Long-term safety and effectiveness of vonoprazan for prevention of gastric and duodenal ulcer recurrence in patients on nonsteroidal anti-inflammatory drugs in Japan: a 12-month post-marketing surveillance study.

Kawai, Takashi; Suzuki, Chihiro; Honda, Youichirou; Fernandez, Jovelle L

Kawai, Takashi; Suzuki, Chihiro; Honda, Youichirou; Fernandez, Jovelle L.

Afiliação

Kawai T; Endoscopy Center, Tokyo Medical University Hospital, Tokyo, Japan.
Suzuki C; Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan.
Honda Y; Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan.
Fernandez JL; Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan.

Expert Opin Drug Saf ; 22(5): 425-431, 2023.

Article em En | MEDLINE | ID: mdl-36264125

Palavras-chave

Anti-inflammatory agents; Potassium-competitive acid blocker; duodenal ulcer; gastric ulcer; non-steroidal; post marketing; product surveillance; vonoprazan

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Screening_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Screening_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article